Trials / Completed
CompletedNCT01533532
A Randomized, Placebo-controlled, Double-blind Study of KLH-2109 in Patients With Endometriosis (2)
A Multicenter, Randomized, Placebo-controlled, Double-blind Phase II Study of KLH-2109 in Patients With Endometriosis(2)
- Status
- Completed
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 100 (planned)
- Sponsor
- Kissei Pharmaceutical Co., Ltd. · Industry
- Sex
- Female
- Age
- 20 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to evaluate the efficacy and safety of KLH-2109 in patients with endometriosis.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | KLH-2109 | |
| DRUG | KLH-2109 | |
| DRUG | KLH-2109 | |
| DRUG | placebo |
Timeline
- First posted
- 2012-02-15
- Last updated
- 2014-05-30
Locations
1 site across 1 country: Japan
Source: ClinicalTrials.gov record NCT01533532. Inclusion in this directory is not an endorsement.